Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides an overview of the Crohn's Disease (Regional Enteritis) (Gastrointestinal) pipeline landscape.
Crohn's disease is an inflammatory bowel disease (IBD). It causes inflammation of the lining of digestive tract, which can lead to abdominal pain, severe diarrhea and even malnutrition. Inflammation caused by Crohn's disease can involve different areas of the digestive tract in different people. Signs and symptoms may include diarrhea, abdominal pain and cramping, blood in stool, ulcers, reduced appetite and weight loss. Risk factor include age, family history, smoking and use of Non-steroidal anti-inflammatory medications.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Crohn's Disease (Regional Enteritis) (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Crohn's Disease (Regional Enteritis) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Crohn's Disease (Regional Enteritis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 14, 21, 29, 47, 15 and 3 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 4 and 2 molecules, respectively.
Crohn's Disease (Regional Enteritis) (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Crohn's Disease (Regional Enteritis) (Gastrointestinal).
- The pipeline guide reviews pipeline therapeutics for Crohn's Disease (Regional Enteritis) (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Crohn's Disease (Regional Enteritis) (Gastrointestinal) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Crohn's Disease (Regional Enteritis) (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Crohn's Disease (Regional Enteritis) (Gastrointestinal)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Crohn's Disease (Regional Enteritis) (Gastrointestinal).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Crohn's Disease (Regional Enteritis) (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Crohn's Disease (Regional Enteritis) - Pipeline Review, H1 2018
Table of Contents
Table of Contents 2
Introduction 6
Crohn's Disease (Regional Enteritis) - Overview 7
Crohn's Disease (Regional Enteritis) - Therapeutics Development 8
Crohn's Disease (Regional Enteritis) - Therapeutics Assessment 26
Crohn's Disease (Regional Enteritis) - Companies Involved in Therapeutics Development 38
Crohn's Disease (Regional Enteritis) - Drug Profiles 75
Crohn's Disease (Regional Enteritis) - Dormant Projects 370
Crohn's Disease (Regional Enteritis) - Discontinued Products 379
Crohn's Disease (Regional Enteritis) - Product Development Milestones 381
Appendix 393
List of Tables
Number of Products under Development for Crohn's Disease (Regional Enteritis), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by 4D Pharma PLC, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by AbbVie Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Adello Biologics LLC, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Aerpio Therapeutics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by AlfaSigma SpA, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Allergan Plc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Alpha Cancer Technologies Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Alteogen Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Amgen Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Aptevo Therapeutics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by ARA Healthcare Pvt Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Arven Ilac, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Atlantic Bio Sci LLC, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Atlantic Healthcare Plc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Bioleaders Corp, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by BioLingus AG, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Boehringer Ingelheim GmbH, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Celgene Corp, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Celltrion Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by ChemoCentryx Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by ChironWells GmbH, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Coherus BioSciences Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Commence Bio Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Concenter BioPharma Silkim Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Daiichi Sankyo Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by DBV Technologies SA, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by EA Pharma Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Eisai Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Eli Lilly and Co, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Enterome Bioscience SA, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Enzo Biochem Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by ETX Pharma Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Ferring International Center SA, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Fresenius SE & Co KGaA, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by FYB202 GmbH & Co KG, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Galapagos NV, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Genentech Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Genor BioPharma Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by iCo Therapeutics Inc., H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Immune Response BioPharma Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Inception Sciences Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Innovation Pharmaceuticals Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Innovent Biologics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Inspyr Therapeutics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Johnson & Johnson, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Jyant Technologies Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Kang Stem Biotech Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by KPI Therapeutics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Kyowa Hakko Kirin Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Merck & Co Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Mesoblast Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Mitsubishi Tanabe Pharma Corp, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Mycenax Biotech Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Novartis AG, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Oncodesign SA, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by OSE Immunotherapeutics, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Pfenex Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Pfizer Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Protagonist Therapeutics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Protalix BioTherapeutics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Qu Biologics Inc, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Re-Pharm Ltd, H1 2018
Crohn's Disease (Regional Enteritis) - Pipeline by Rebiotix Inc, H1 2018
List of Figures
Number of Products under Development for Crohn's Disease (Regional Enteritis), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Top 10 Molecule Types, H1 2018
Number of Products by Stage and Top 10 Molecule Types, H1 2018
Global Crohn'S Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 110
Market Overview of Global Crohn'S Disease Drug market:
According to our latest research, the global Crohn'S Disease Drug market looks promising in the next 5 years. As of 2022, the global Crohn'S Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Crohn's disease drugs can reduce inflammation and relieve symptoms
This report covers a research time span from 2018......
Global Crohn'S Disease Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 01-Jun-2023 Price: US 3260 Onwards Pages: 102
Crohn's disease drugs can reduce inflammation and relieve symptoms
The Crohn'S Disease Drug market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Crohn'S Disease Drug industry, and breaks down according to the type, application, and consumption area of Crohn'S Disease Drug. The report also introduces players in the industr......
Global Crohn's Disease Drug Market Research Report 2023, Forecast to 2028
Published: 22-May-2023 Price: US 2680 Onwards Pages: 133
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Global Crohn's Disease Drug Professional Survey Report 2023, Forecast to 2028
Published: 22-May-2023 Price: US 3280 Onwards Pages: 105
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
2023-2031 Report on Global Crohn's Disease Drug Market by Player, Region, Type, Application and Sales Channel
Published: 08-May-2023 Price: US 2500 Onwards Pages: 85
This report studies the Crohn's Disease Drug market, covering market size for segment by type (Aminosalicylates, Corticosteroids, etc.), by application (Adults, Pediatric, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Abbvie, Amgen, Boehringer Ingelheim, Cambridge Antibody Technology, Janssen Biotech, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of g......
Global Crohn'S Disease Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends
Published: 31-Jan-2023 Price: US 3450 Onwards Pages: 124
Crohn's disease drugs can reduce inflammation and relieve symptoms
The report focuses on the Crohn'S Disease Drug market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to ac......
2022-2030 Report on Global Crohn's Disease Drug Market by Player, Region, Type, Application and Sales Channel
Published: 30-May-2022 Price: US 2500 Onwards Pages: 103
This report studies the Crohn's Disease Drug market, covering market size for segment by type (Aminosalicylates, Corticosteroids, etc.), by application (Adults, Pediatric, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Abbvie, Amgen, Boehringer Ingelheim, Cambridge Antibody Technology, Janssen Biotech, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of g......
Global Crohn's Disease Drug Professional Survey Report 2022, Forecast to 2027
Published: 11-Feb-2022 Price: US 3280 Onwards Pages: 101
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the imp......
Global Crohn's Disease Drug Market Research Report 2022, Forecast to 2027
Published: 11-Feb-2022 Price: US 2680 Onwards Pages: 136
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the imp......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
